4Shao LK.Determination of paclitaxel and related Taxane in bulk drug and injectable doseage forms by Reversed-phase high-performance liquid chromatography [J].Anal Chem.1997,69(11):2008.
5Neijt JP, Engelhom SA, Tuxen MK, etal.Exploratory phase study of paclitaxel and cisplatin versus paclitaxel and carboplatinin advanced ovarian cancer.[J].J Clin Oncol,2000,18(17):3084-3092.
6Gatzameier U, Pawel JV, Gottfried M, et al. Phase comparative study of high-dosecisplatin in patients with advanced non-small-cell lung cancer[J].J ClinOncol,2000,18(19):3390-3399.
7Gelmon K, Eisenhauer E, Bryce C, et al. Randomized phaseⅡstudy of high-dosepaclitaxel with or without amifostine in patients with metastatic breast cancer[J].J ClinOncol,1999,17(10):3038-3047.
8Weiss RB, Donehower RC, Wiernik PH, et al. Hypersensitivity reaction from taxol[J].J Clin Oncol,1990,8(7):1263-1268.
9Olson JK, Sood AK, Sorosky JI, et al. Taxol hypersensitivity: rapid retreatment issafe and cost effective[J]. J Gynecol Oncol,1998,68(1):25-28.
10Markman M, Kennedy A,Webster K,et al. Paclitaxel-associated hypersensitivityreactions:experience of the gynecologic oncology program of the cleveland clinic cancercenter[J]. J Clin Oncol,2000,18(1):102-105.
